Palitra Bio
Palitra Bio tests candidate treatments directly against a patient's own tumour cells, with a PhD data team and an MD tumour board turning the results into a personalised treatment plan.
Overview
Palitra Bio offers what it calls maximalist functional testing: rational therapeutic options are tested against the patient's own tumour cells, matched to malignancy, stage and goals of care, and synthesised by a data team and a medical tumour board into guidance for the treating clinicians. Its chief executive brings fifteen years at the intersection of cancer biology and translational research. It is an Even One Ventures portfolio company.
Funding
All startupsSimilar pages
not linked directly; found by shared links- CompanyValius Sciences
Shares Even One Ventures, Functional (ex vivo) drug testing and the tags startup, evenone-portfolio, oncology.
- CompanyKernis Health
Shares Even One Ventures, Functional (ex vivo) drug testing and the tags startup, evenone-portfolio, oncology.
- CompanyRelit Biosciences
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyRanata Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyYuga Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyInvocata
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyMinuteman Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.